tiprankstipranks
Early notable gainers among liquid option names on March 10th
PremiumThe FlyEarly notable gainers among liquid option names on March 10th
13d ago
Unusually active option classes on open March 10th
Premium
The Fly
Unusually active option classes on open March 10th
13d ago
Eisai, Biogen announce TGA of Australia declined approval of lecanemab
Premium
The Fly
Eisai, Biogen announce TGA of Australia declined approval of lecanemab
20d ago
Biogen price target lowered to $135 from $138 at Piper Sandler
PremiumThe FlyBiogen price target lowered to $135 from $138 at Piper Sandler
1M ago
QQQ ETF News, 2/17/2025
Premium
Market News
QQQ ETF News, 2/17/2025
1M ago
Biogen’s Growth Potential Amidst Challenges: A Buy Rating by Marc Goodman
Premium
Ratings
Biogen’s Growth Potential Amidst Challenges: A Buy Rating by Marc Goodman
1M ago
Biogen price target lowered to $135 from $166 at Wedbush
PremiumThe FlyBiogen price target lowered to $135 from $166 at Wedbush
1M ago
Biogen price target lowered to $200 from $275 at TD Cowen
Premium
The Fly
Biogen price target lowered to $200 from $275 at TD Cowen
1M ago
Biogen price target lowered to $157 from $192 at Morgan Stanley
Premium
The Fly
Biogen price target lowered to $157 from $192 at Morgan Stanley
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100